Joshua Dennerlein
Stock Analyst at B of A Securities
(2.21)
# 2,658
Out of 4,873 analysts
95
Total ratings
44.62%
Success rate
-4.37%
Average return
Main Sectors:
Stocks Rated by Joshua Dennerlein
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| FVR FrontView REIT | Downgrades: Underperform | $15 → $11 | $11.99 | -8.26% | 2 | Jun 17, 2025 | |
| SUI Sun Communities | Maintains: Underperform | $124 → $132 | $128.49 | +2.74% | 3 | May 12, 2025 | |
| TRI Thomson Reuters | Reinstates: Neutral | $180 | $197.49 | -8.86% | 1 | Apr 10, 2025 | |
| CTAS Cintas | Reinstates: Buy | $250 | $222.71 | +12.25% | 1 | Apr 10, 2025 | |
| MSCI MSCI Inc. | Initiates: Neutral | $585 | $576.49 | +1.48% | 1 | Apr 10, 2025 | |
| VRSK Verisk Analytics | Reinstates: Underperform | $280 | $309.66 | -9.58% | 1 | Apr 10, 2025 | |
| WELL Welltower | Maintains: Buy | $221 → $242 | $155.03 | +56.10% | 7 | Feb 18, 2025 | |
| GTY Getty Realty | Upgrades: Buy | $31 → $34 | $28.89 | +17.69% | 3 | Oct 21, 2024 | |
| AHR American Healthcare REIT | Maintains: Buy | $27 → $31 | $36.43 | -14.89% | 2 | Sep 24, 2024 | |
| NHI National Health Investors | Initiates: Buy | $92 | $72.30 | +27.25% | 1 | Sep 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $307 → $321 | $287.38 | +11.70% | 3 | Sep 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $100 | $46.53 | +114.92% | 1 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $111 → $147 | $116.08 | +26.64% | 4 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $144 → $189 | $149.52 | +26.40% | 3 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $45 → $40 | $58.26 | -31.34% | 4 | May 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $18 → $25 | $17.50 | +42.86% | 2 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $33 → $31 | $37.15 | -16.55% | 11 | Jan 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $48 → $53 | $63.34 | -16.32% | 9 | Jan 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $18 → $6 | $6.81 | -11.89% | 1 | Nov 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $42 → $33 | $41.09 | -19.69% | 1 | Oct 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $20 → $15 | $16.84 | -10.93% | 2 | Oct 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $52 | $58.10 | -10.50% | 1 | Oct 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $18.56 | - | 4 | Oct 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $67 → $54 | $64.42 | -16.18% | 4 | Sep 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $9 → $8 | $4.49 | +78.17% | 9 | Aug 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | $27 | $13.39 | +101.72% | 1 | Jun 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $28 → $34 | $17.43 | +92.20% | 5 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $32.75 | - | 4 | Aug 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $76 → $78 | $75.00 | +4.00% | 2 | Jun 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $52 → $47 | $43.05 | +9.18% | 2 | Jan 20, 2022 |
FrontView REIT
Jun 17, 2025
Downgrades: Underperform
Price Target: $15 → $11
Current: $11.99
Upside: -8.26%
Sun Communities
May 12, 2025
Maintains: Underperform
Price Target: $124 → $132
Current: $128.49
Upside: +2.74%
Thomson Reuters
Apr 10, 2025
Reinstates: Neutral
Price Target: $180
Current: $197.49
Upside: -8.86%
Cintas
Apr 10, 2025
Reinstates: Buy
Price Target: $250
Current: $222.71
Upside: +12.25%
MSCI Inc.
Apr 10, 2025
Initiates: Neutral
Price Target: $585
Current: $576.49
Upside: +1.48%
Verisk Analytics
Apr 10, 2025
Reinstates: Underperform
Price Target: $280
Current: $309.66
Upside: -9.58%
Welltower
Feb 18, 2025
Maintains: Buy
Price Target: $221 → $242
Current: $155.03
Upside: +56.10%
Getty Realty
Oct 21, 2024
Upgrades: Buy
Price Target: $31 → $34
Current: $28.89
Upside: +17.69%
American Healthcare REIT
Sep 24, 2024
Maintains: Buy
Price Target: $27 → $31
Current: $36.43
Upside: -14.89%
National Health Investors
Sep 24, 2024
Initiates: Buy
Price Target: $92
Current: $72.30
Upside: +27.25%
Sep 24, 2024
Downgrades: Neutral
Price Target: $307 → $321
Current: $287.38
Upside: +11.70%
Aug 19, 2024
Initiates: Buy
Price Target: $100
Current: $46.53
Upside: +114.92%
Aug 12, 2024
Upgrades: Buy
Price Target: $111 → $147
Current: $116.08
Upside: +26.64%
Aug 12, 2024
Upgrades: Buy
Price Target: $144 → $189
Current: $149.52
Upside: +26.40%
May 20, 2024
Downgrades: Underperform
Price Target: $45 → $40
Current: $58.26
Upside: -31.34%
Apr 1, 2024
Upgrades: Buy
Price Target: $18 → $25
Current: $17.50
Upside: +42.86%
Jan 16, 2024
Downgrades: Neutral
Price Target: $33 → $31
Current: $37.15
Upside: -16.55%
Jan 16, 2024
Upgrades: Buy
Price Target: $48 → $53
Current: $63.34
Upside: -16.32%
Nov 7, 2023
Downgrades: Underperform
Price Target: $18 → $6
Current: $6.81
Upside: -11.89%
Oct 31, 2023
Downgrades: Neutral
Price Target: $42 → $33
Current: $41.09
Upside: -19.69%
Oct 10, 2023
Downgrades: Underperform
Price Target: $20 → $15
Current: $16.84
Upside: -10.93%
Oct 10, 2023
Downgrades: Neutral
Price Target: $52
Current: $58.10
Upside: -10.50%
Oct 10, 2023
Upgrades: Buy
Price Target: n/a
Current: $18.56
Upside: -
Sep 26, 2023
Maintains: Underperform
Price Target: $67 → $54
Current: $64.42
Upside: -16.18%
Aug 11, 2023
Downgrades: Underperform
Price Target: $9 → $8
Current: $4.49
Upside: +78.17%
Jun 13, 2023
Initiates: Underperform
Price Target: $27
Current: $13.39
Upside: +101.72%
Nov 14, 2022
Upgrades: Buy
Price Target: $28 → $34
Current: $17.43
Upside: +92.20%
Aug 24, 2022
Upgrades: Buy
Price Target: n/a
Current: $32.75
Upside: -
Jun 2, 2022
Upgrades: Buy
Price Target: $76 → $78
Current: $75.00
Upside: +4.00%
Jan 20, 2022
Downgrades: Underperform
Price Target: $52 → $47
Current: $43.05
Upside: +9.18%